
    
      The study included the patients diagnosed with gastric cancer during the period between March
      1, 2020, and December 31, 2020, in the pandemic group at the Adana City Training and Research
      Hospital, Department of General Surgery, Divisions of Gastroenterological Surgery and
      Surgical Oncology. For the baseline group, patients diagnosed with gastric cancer between
      January 1, 2019, and December 31, 2019, was included in the same department.

      Clinical and pathological data of the patients were retrospectively collected from the
      hospital medical records. The following parameters were compared between the pandemic and
      baseline periods; age and gender distributions, mean monthly numbers of newly diagnosed
      patients, CEA and CEA-19.9 levels, the type of the surgery, the location of the tumor, the
      frequency of the patients receiving neoadjuvant treatment, American Society of
      Anesthesiologists (ASA) score, length of the hospital stay, clinical staging and pathologic
      TNM staging.
    
  